Viemed Healthcare, Inc.
VMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $72 | $63 | $59 | $61 |
| % Growth | 14% | 6.6% | -2.6% | – |
| Cost of Goods Sold | $31 | $27 | $26 | $25 |
| Gross Profit | $41 | $36 | $33 | $36 |
| % Margin | 57.5% | 57.7% | 56.3% | 59.5% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $31 | $31 | $30 |
| SG&A Expenses | $33 | $31 | $31 | $30 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2 | -$0 | -$2 | -$1 |
| Operating Expenses | $36 | $32 | $29 | $30 |
| Operating Income | $6 | $5 | $4 | $6 |
| % Margin | 7.8% | 7.2% | 6.5% | 10.6% |
| Other Income/Exp. Net | -$1 | $0 | -$0 | -$0 |
| Pre-Tax Income | $5 | $5 | $4 | $6 |
| Tax Expense | $2 | $2 | $1 | $2 |
| Net Income | $4 | $3 | $3 | $4 |
| % Margin | 4.9% | 5% | 4.4% | 7.1% |
| EPS | 0.09 | 0.08 | 0.07 | 0.11 |
| % Growth | 12.6% | 14.1% | -36.4% | – |
| EPS Diluted | 0.09 | 0.077 | 0.06 | 0.1 |
| Weighted Avg Shares Out | 39 | 40 | 39 | 39 |
| Weighted Avg Shares Out Dil | 40 | 41 | 42 | 42 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $8 | $7 | $7 | $6 |
| EBITDA | $13 | $12 | $10 | $13 |
| % Margin | 18.3% | 19% | 17.7% | 21.1% |